References
- Laird JR, Katzen BT, Scheinert D et al. Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery. Twelve-month results from the RESILIENT randomized trial. Circ. Cardiovasc. Interv.3, 267–276 (2010).
- Jaff MR, Dake MD, Popma JJ, Ansel G, Yoder T. Standardized evaluation and reporting of stent fractures in clinical trials of non-coronary devices. Cathet. Cardiovasc. Interv.70, 460–462 (2007).
- Rocha-Singh K, Jaff MR, Crabtree TR, Bloch DA, Ansel G. Performance goals and end point assessments for clinical trials of femoropopliteal bare Nitinol stents in patients with symptomatic peripheral arterial disease. Cathet. Cardiovasc. Interv.69, 910–919 (2007).
- Tepe G, Zeller T, Albrecht T et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N. Engl. J. Med.358, 689–699 (2008).
- Yancey AE, Minion DJ, Rodriguez C, Patterson DE, Endean ED. Peripheral atherectomy in TransAtlantic InterSociety Consensus type C femoropopliteal lesions for limb salvage. J. Vasc. Surg.44, 503–509 (2006).
- Brott TG, Hobson RW, Howard G et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N. Engl. J. Med.363, 11–23 (2010).
- Greenhalgh RM, Brown LC, Powell JT, Thompson SG, Epstein D; United Kingdom EVAR Trial Investigators. Endovascular repair of aortic aneurysm in patients physically ineligible for open repair. N. Engl. J. Med.362, 1872–1880 (2010).